Exploring promising minor natural phenolic compounds in neuroprotection‐related preclinical models
Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterised by the progressive loss of specific neuronal cell populations due to multifactorial factors, including neurochemical and immunological disturbances. Consequently, patients can develop cogniti...
Saved in:
Published in | Basic & clinical pharmacology & toxicology Vol. 134; no. 6; pp. 770 - 777 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterised by the progressive loss of specific neuronal cell populations due to multifactorial factors, including neurochemical and immunological disturbances. Consequently, patients can develop cognitive, motor and behavioural dysfunctions, which lead to impairments in their quality of life. Over the years, studies have reported on the neuroprotective properties inherent in phenolic compounds. Therefore, this review highlights the most recent scientific findings regarding phenolic compounds as promising neuroprotective molecules against neurodegenerative diseases. |
---|---|
Bibliography: | Died February 6, 2024. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 1742-7835 1742-7843 |
DOI: | 10.1111/bcpt.14006 |